TREE NEWS reports: A total of 156 Chinese mutual fund firms conducted 10,613 research visits to A-share listed companies in October, covering 525 stocks across 29 Shenwan level-1 industries, a 228.58% month-on-month increase. Pharmaceuticals and biotechnology drew the most attention with 2,101 visits across 77 stocks, followed by electronics with 1,639 visits covering 81 stocks. Machinery, power equipment, computers and light manufacturing each received at least 600 visits.
Chinese Mutual Funds Log 10,613 A-Share Research Visits in October, Up 228.58%
AI take
The breadth of October's research surge — 156 fund firms spanning 29 industries — suggests a broad re-engagement with A-shares rather than a narrow sector bet, which makes the concentration in pharma/biotech and electronics notable as the clearest pockets of conviction. For listed companies, elevated visit volume can signal closer scrutiny of fundamentals ahead of positioning decisions. Whether this pace persists into November, and whether pharma's lead over electronics widens or narrows, is the open question worth tracking.
Generated by AI for reference only.
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
8m ago
Shanghai Composite Opens Down 0.37% at 3,624.58
11m ago
China’s Central Bank Conducts 621 Billion Yuan Overnight Reverse Repo
12m ago
Hang Seng Opens Up 0.33% at 23,469.64; Hang Seng Tech Rises 0.36%
18m ago
PBOC Sets Yuan Midpoint at 6.7150, 4 Pips Weaker Than Previous Fix
33m ago
Taiwan Weighted Index Opens Down 1.1% at 44,423.41
34m ago
China commodity futures open sharply lower; crude oil main contract falls over 7%